Log in
Enquire now
‌

US Patent 11608362 Hepatitis B vaccines and uses of the same

Patent 11608362 was granted and assigned to Precigen on March, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Precigen
Precigen
0
Current Assignee
Precigen
Precigen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116083620
Patent Inventor Names
Ramya Yarlagadda0
Prabakaran Ponraj0
Vinodhbabu Kurella0
Simon Metenou0
Cheryl G. Bolinger0
Douglas E. Brough0
Kuan-Fu Ding0
Date of Patent
March 21, 2023
0
Patent Application Number
169785700
Date Filed
March 6, 2019
0
Patent Primary Examiner
‌
Nianxiang Zou
0

Provided herein are engineered hepatitis B virus (HBV) molecular vaccine constructs. Vaccine constructs can also include ligand-inducible engineered gene switch systems for modulating expression of heterologous genes, such as a cytokines, in host cells.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11608362 Hepatitis B vaccines and uses of the same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us